Gliomas Benign

2

Review clinical trials related to Gliomas Benign. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas

This study uses a cranial implant to deliver cortical stimulation that, when paired with physiotherapy, will remap the brain so that critical brain functions can be protected during brain tumor surgery. This pilot study will provide initial evidence for the safety and feasibility of such a protocol which will lead to future pivotal trials that could radically change eloquent area brain surgery. For patients with otherwise incompletely resectable brain tumors, this could mean a longer life expectancy and a better quality of life.

Participants needed: 3
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Medical College of WisconsinUpdated: Jan 12, 2026
Eligibility criteria

Age 18-65 years old [+7]

Presence of other malignancy not in remission [+14]

Status: Recruiting

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since 2001, and who have had magnetic resonance (MR) re-examination after first MR exam or will be re-examined because it was determined that immediate treatment would not be needed at the first visit to the hospital. In all MRs taken by patients, the date of imaging and the volume of the tumor are measured, and we aim to establish a natural growth history for non-malignant brain tumors.

Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Seoul National University HospitalUpdated: Dec 3, 2024Locations: 1Duration: 15 Years
Eligibility criteria

Patients with radiologically diagnosed brain neoplasm of CNS WHO grade 2 or less... [+11]

Patients who lost follow-up before the second MR exam [+2]